Market revenue in 2023 | USD 798.7 million |
Market revenue in 2030 | USD 1,945.2 million |
Growth rate | 13.6% (CAGR from 2023 to 2030) |
Largest segment | Hydrogels |
Fastest growing segment | Micropatterned Surface Microplates |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hydrogels, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds |
Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Tecan Group AG, Becton Dickinson & Co, Medtronic PLC, Matricelf Ltd, Corning Inc, Avacta Group PLC, Vericel Corp, NuVasive, Allergan, ReproCELL, 3D Biotek, Xanofi, Molecular Matrix, Pelo Biotech, Azenta Life Sciences, Akron Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to scaffold technology market will help companies and investors design strategic landscapes.
Hydrogels was the largest segment with a revenue share of 41.83% in 2023. Horizon Databook has segmented the North America scaffold technology market based on hydrogels, polymeric scaffolds, micropatterned surface microplates, nanofiber based scaffolds covering the revenue growth of each sub-segment from 2018 to 2030.
North America accounted for the largest revenue share in 2020 and is expected to maintain its lead over the forecast period. The presence of a comparatively substantial number of key players operating in this region and their involvement in development of scaffold technology are attributive to its leading share.
Some of the key companies operating in the North American market are Thermo Fisher Scientific Inc., 3D Biotek LLC, Molecular Matrix Inc., and Corning Incorporated. Strategic initiatives undertaken by key companies in this region to reinforce their market presence drives the usage of scaffold technology across a wide range of applications.
For instance, in September 2019, the acquisition of a majority interest of Akron Biotech by Arcline Investment Management expanded Akron’s capabilities to fulfill the growing demand for regenerative medicine using scaffold technology.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America scaffold technology market , including forecasts for subscribers. This continent databook contains high-level insights into North America scaffold technology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account